Registro:

Referencias:

• Chowdhury, U.K., Groundwater arsenic contamination in Bangladesh and West Bengal, India (2000) Environ. Health. Perspect., 108, pp. 393-397
• Dittmar, J., Arsenic in soil and irrigation water affects arsenic uptake by rice: Complementary insights from field and pot studies (2010) Environ. Sci. Technol, 44, pp. 8842-8848
• States, J.C., Arsenic toxicology: Translating between experimental models and human pathology (2011) Environ. Health Perspect., 119, pp. 1356-1363
• Naujokas, M.F., The broad scope of health effects from chronic arsenic exposure: Update on a worldwide public health problem (2013) Environ. Health Perspect, 121, pp. 295-302
• Wang, T.C., Jan, K.Y., Wang, A.S., Gurr, J.R., Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells (2007) Mutat. Res, 615, pp. 75-86
• States, J.C., Srivastava, S., Chen, Y., Barchowsky, A., Arsenic and cardiovascular disease (2009) Toxicol. Sci, 107, pp. 312-323
• Wade, T.J., Increased mortality associated with well-water arsenic exposure in Inner Mongolia, China (2009) Int. J. Environ. Res. Public. Health, 6, pp. 1107-1123
• Moon, K., Guallar, E., Navas-Acien, A., Arsenic exposure and cardiovascular disease: An updated systematic review (2012) Curr. Atheroscler. Rep, 14, pp. 542-555
• Chen, Y., Karagas, M.R., Arsenic and cardiovascular disease: New evidence from the United States (2013) Ann. Intern. Med, 159, pp. 713-714
• Jomova, K., Arsenic: Toxicity, oxidative stress and human disease (2011) J. Appl. Toxicol, 31, pp. 95-107
• Smith, A.H., Steinmaus, C.M., Arsenic in drinking water (2011) BMJ, 342
• Chen, C.J., Increased prevalence of hypertension and long-term arsenic exposure (1995) Hypertension, 25, pp. 53-60
• Rahman, M., Hypertension and arsenic exposure in Bangladesh (1999) Hypertension, 33, pp. 74-78
• Wang, C.H., Biological gradient between long-term arsenic exposure and carotid atherosclerosis (2002) Circulation, 105, pp. 1804-1809
• Lewis, D.R., Southwick, J.W., Ouellet-Hellstrom, R., Rench, J., Calderon, R.L., Drinking water arsenic in Utah: A cohort mortality study (1999) Environ. Health Perspect, 107, pp. 359-365
• Medrano, M.A., Arsenic in public water supplies and cardiovascular mortality in Spain (2010) Environ. Res, 110, pp. 448-454
• Chen, C.J., Chiou, H.Y., Chiang, M.H., Lin, L.J., Tai, T.Y., Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure (1996) Arterioscler. Thromb. Vasc. Biol, 16, pp. 504-510
• Tseng, C.H., Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan (2003) Toxicol. Lett, 137, pp. 15-21
• Quansah, R., Association of Arsenic with Adverse Pregnancy Outcomes-Infant Mortality: A Systematic Review and Meta- Analysis (2015) Environ. Health Perspect, 27
• Chen, Y., Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: Prospective cohort study (2011) BMJ, 342
• Raghu, K.G., Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug (2009) J. Environ. Pathol. Toxicol. Oncol, 28, pp. 241-252
• Shen, Z.X., All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia (2004) Proc. Natl. Acad. Sci. USA, 101, pp. 5328-5335
• Wang, Z.Y., Chen, Z., Acute promyelocytic leukemia: From highly fatal to highly curable (2008) Blood, 111, pp. 2505-2515
• Platanias, L.C., Biological responses to arsenic compounds (2009) J. Biol. Chem, 284, pp. 18583-18587
• Zhao, X., Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: Implications in cardiotoxicity (2008) Basic. Clin. Pharmacol. Toxicol, 102, pp. 419-425
• Sumi, D., Sasaki, T., Miyataka, H., Himeno, S., Rat H9c2 cardiac myocytes are sensitive to arsenite due to a modest activation of transcription factor Nrf2 (2011) Arch. Toxicol, 85, pp. 1509-1516
• Stummann, T.C., Hareng, L., Bremer, S., Embryotoxicity hazard assessment of cadmium and arsenic compounds using embryonic stem cells (2008) Toxicology, 252, pp. 118-122
• Wang, Q.Q., Effect of arsenic compounds on the in vitro differentiation of mouse embryonic stem cells into cardiomyocytes (2015) Chem. Res. Toxicol, 28, pp. 351-353
• Boheler, K.R., Differentiation of pluripotent embryonic stem cells into cardiomyocytes (2002) Circ. Res, 91, pp. 189-201
• Mercola, M., Ruiz-Lozano, P., Schneider, M.D., Cardiac muscle regeneration: Lessons from development (2011) Genes Dev, 25, pp. 299-309
• Naranmandura, H., Suzuki, N., Suzuki, K.T., Trivalent arsenicals are bound to proteins during reductive methylation (2006) Chem. Res. Toxicol, 19, pp. 1010-1018
• Cullen, W., R. Chemical mechanism of arsenic biomethylation (2014) Chem. Res. Toxicol, 27, pp. 457-461
• Wobus, A.M., Guan, K., Yang, H.T., Boheler, K.R., Embryonic stem cells as a model to study cardiac, skeletal muscle, and vascular smooth muscle cell differentiation (2002) Methods Mol. Biol, 185, pp. 127-156
• Heikinheimo, M., Scandrett, J.M., Wilson, D.B., Localization of transcription factor GATA-4 to regions of the mouse embryo involved in cardiac development (1994) Dev. Biol, 164, pp. 361-373
• Ip, H.S., The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells (1994) Mol. Cell Biol, 14, pp. 7517-7526
• Monzen, K., Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase TAK1 and cardiac transcription factors Csx/Nkx-2. 5 and GATA-4 (1999) Mol. Cell Biol, 19, pp. 7096-7105
• Kehat, I., Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes (2001) J. Clin. Invest, 108, pp. 407-414
• Xu, C., Police, S., Rao, N., Carpenter, M.K., Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells (2002) Circ. Res, 91, pp. 501-508
• Fassina, L., Video evaluation of the kinematics and dynamics of the beating cardiac syncytium: An alternative to the Langendorff method (2011) Int. J. Artif. Organs, 34, pp. 546-558
• Boheler, K.R., Crider, D.G., Tarasova, Y., Maltsev, V.A., Cardiomyocytes derived from embryonic stem cells (2005) Methods Mol. Med, 108, pp. 417-435
• Van Halem, D., Bakker, S.A., Amy, G.L., Van Dijk, J.C., Arsenic in drinking water: A worldwide water quality concern for water supply compagnie (2009) Drink Water Eng. Sci, 2, pp. 29-34
• Durocher, D., Charron, F., Warren, R., Schwartz, R.J., Nemer, M., The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors (1997) EMBO J, 15, pp. 5687-5696
• Lien, C.L., Control of early cardiac-specific transcription of Nkx2-5 by a GATA-dependent enhancer (1999) Development, 126, pp. 75-84
• Riazi, A.M., NKX2-5 regulates the expression of beta-catenin and GATA4 in ventricular myocytes (2009) PLoS One, 4, p. e5698
• Verma, V., Manasi, P.K., Shim, W., Steering signal transduction pathway towards cardiac lineage from human pluripotent stem cells: A review (2013) Cell Signal, 25, pp. 1096-1107
• Hong, G.M., Bain, L.J., Arsenic exposure inhibits myogenesis and neurogenesis in P19 stem cells through repression of the -catenin signaling pathway (2012) Toxicol. Sci, 129, pp. 146-156
• Yen, Y.P., Arsenic inhibits myogenic differentiation and muscle regeneration (2010) Environ. Health Perspect, 118, pp. 949-956
• Steffens, A.A., Hong, G.M., Bain, L.J., Sodium arsenite delays the differentiation of C2C12 mouse myoblast cells and alters methylation patterns on the transcription factor myogenin (2011) Toxicol. Appl. Pharmacol, 250, pp. 154-161
• Sumi, D., Abe, K., Himeno, S., Arsenite retards the cardiac differentiation of rat cardiac myoblast H9c2 cells (2013) Biochem. Biophys. Res. Commun, 436, pp. 175-179
• Thompson, B.R., Metzger, J.M., Cell biology of sarcomeric protein engineering: Disease modeling and therapeutic potential (2014) Anat. Rec. (Hoboken), 297, pp. 1663-1669
• Chou, Y., Endothelial gap junctions are down-regulated by arsenic trioxide (2007) Eur. J. Pharmacol, 569, pp. 29-36
• Vink, M.J., Alterations of intercellular communication in neonatal cardiac myocytes from connexin43 null mice (2004) Cardiovasc. Res, 62, pp. 397-406
• Mo, J., Altered gene expression by low-dose arsenic exposure in humans and cultured cardiomyocytes: Assessment by realtime PCR arrays (2011) Int. J. Environ. Res. Public Health, 8, pp. 2090-2108
• Farzan, S.F., Karagas, M.R., Chen, Y., In utero and early life arsenic exposure in relation to long-term health and disease (2013) Toxicol. Appl. Pharmacol, 272, pp. 384-390
• Rebuzzini, P., Mouse embryonic stem cells that survive ? -rays exposure maintain pluripotent differentiation potential and genome stability (2012) J. Cell. Physiol, 227, pp. 1242-1249
• Neri, T., The differentiation of cardiomyocytes from mouse embryonic stem cells is altered by dioxin (2011) Toxicol. Lett, 202, pp. 226-236
• Rebuzzini, P., Mouse embryonic stem cells irradiated with? -rays differentiate into cardiomyocytes but with altered contractile properties (2013) Mutat. Res, 756, pp. 37-45
• Banda, M., Bommineni, A., Thomas, R.A., Luckinbill, L.S., Tucker, J.D., Evaluation and validation of housekeeping genes in response to ionizing radiation and chemical exposure for normalizing RNA expression in real-time PCR (2008) Mutat. Res, 649, pp. 126-134
• Zur Nieden, N.I., Kempka, G., Ahr, H.J., Molecular multiple endpoint embryonic stem cell test-a possible approach to test for the teratogenic potential of compounds (2004) Toxicol. Appl. Pharmacol, 194, pp. 257-269

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------